Researchers will test an experimental drug that could prevent Alzheimer’s disease in people who are genetically slated to develop Alzheimer’s disease but have yet to exhibit symptoms. On Tuesday, the federal government unveiled its National Alzheimer’s Plan to find effective ways to prevent and treat dementia and Alzheimer’s by 2025. On Wednesday, the plan’s scope [...]
Posts Tagged ‘Drug’
The Alzheimer’s Disease Drug Market Will Nearly Triple Over the Next Ten Years, Increasing from $5.4 Billion in 2010 to $14.3 Billion in 2020 | Alzheimer’s Articles, Information and Resources
October 6th, 2011 
admin Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the Alzheimer’s disease drug market will nearly triple over the next ten years, increasing from $5.4 billion in 2010 to $14.3 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. [...]
Posted in Articles, Resources 
Tags: adjunctive, advisory firm, Alzheimers, Alzheimers Doctors, Alzheimer’s, alzheimer’s articles, alzheimer’s assisted living, Alzheimer’s Awareness, alzheimer’s blog, alzheimer’s care facilities, Alzheimer’s Disease, Alzheimer’s Disease Neuroimaging Initiative, alzheimer’s hospitals, alzheimer’s information, alzheimer’s nursing homes, alzheimer’s prevention, Alzheimer’s Research, alzheimer’s resources, alzheimer’s retirement community, alzheimer’s retirement homes, alzheimer’s risk factors, alzheimer’s senior living, alzheimer’s senior living facilities, Alzheimer’s Treatments, anti-beta-amyloid, antibodies, Articles, bapineuzumab, beta amyloid, biological, Brain, Care, Causes, clinical, commercial, Decision Resources, Dementia, Disease, disease-modifying, Doctors, Drug, drug market, Eli Lilly, generic, healthcare, Hospital, inhibitors, late-stage, Market, market growth, monoclonal, Nearly, neurodegeneration, Neurological, Next, Over, Pfizer, pharmaceutical, Prevent, Preventatives, Research, Senior, solanezumab, Ten, therapies, Treatment, Treatments, Triple, Years 
No Comments »
Potential Target for Treating Common Form of Early-Onset Dementia Identified
September 29th, 2011 admin No cure exists for frontotemporal dementia, which strikes between the ages of 40 and 64 and accounts for at least one in four cases of early-onset dementia. Caused by the death of cells in the front and sides of the brain, the disease can lead to dramatic changes in a patient’s personality and behavior, including [...]
Posted in Articles, Resources Tags: activity, alleviate, Alzheimer's Foundation, behavior, communicate, Consortium for Frontotemporal Dementia, Cure, David Geffen, Dementia, Disease, disorder, Dr. Daniel Geschwind, Drug, early-onset, frontotemporal, genetic, John Douglas French Alzheimer's Foundation, mental health, National Institute for Neurological Disease and Stroke, National Institute of Aging, National Institute of Mental Health, neurology, new drug, personality, Reference, Research, Semel Institute, Semel Institute for Neuroscience and Human Behavior, stem cells, symptoms, The journal Neuron, Treatment, UC San Francisco, UCLA, University of California Los Angeles No Comments »
Non-Prescription Treatments and Preventatives Help Alzheimer’s Disease
September 24th, 2011 admin A recently published study on a popular Alzheimer’s disease drug demonstrated that there is no significant difference between patients taking the prescription drug and those taking a placebo. With one in seven Americans over the age of 71 affected by some form of dementia, the popularity of pharmaceuticals that offer any glimmer of hope is [...]
Posted in Articles, Resources Tags: Archives of Neurology, cognitive performance, Community, Dementia, Drug, Drugs and Aging, fatty acids, foods, Ginkgo Biloba, healthcare, Help Alzheimer's, Los Angeles, memory improvements, Natural, Non-Prescription Treatments, omega-3, Pharmaceuticals, prescription, prescription medications, prevent memory loss, preventing, Research, San Diego, Study, supplements, symptoms, turmeric, UCLA, University of California Los Angeles No Comments »
5 Easy Ways To Prevent Alzheimer’s
September 24th, 2011 admin Ignore mainstream medicine’s “remedies” for mental problems. There are several safer and less expensive alternatives for mild or acute levels of dementia. Mild levels of dementia include mental fog and forgetfulness. Acute dementia includes Alzheimer’s disease. And other mental issues regardless of age have some worthwhile alternative remedies as well. NOTE: For more information on [...]
Posted in Articles, Resources Tags: age, alzheimer's disease, coconut oil, decreasing, Dementia, depression, Dietary, Drug, exercise, forgetfulness, Illinois, medicine, memory, Mental Disorders, niacin, organic foods, Paul Fassa, prevent Alzheimer's, reducing Alzheimer's risk, remedies, Sage, vitamin No Comments »
Mature brain or Alzheimer’s brain – which do you have?
September 24th, 2011 admin If you’re over 50, chances are you’ve begun to notice some memory loss. Even in perfectly healthy adults with exceedingly active brains, the hippocampus – a part of the brain important to the formation of memories – begins to atrophy around the age of 55. As this happens, no doubt you begin to wonder, with [...]
Posted in Articles, Resources Tags: active, aging, Alzheimer's brain, Alzheimers, Amyloid, Anton Bruckner, anxiety, coconut oil, Disease, Drug, George Burns, George H.W. Bush, health food, healthy, holistic health, Jimmy Carter, medical treatment, memory loss, mental, National Academy of Sciences, Protein, Research, The Journal of Neuroscience, Treatment, walking, Winston Churchill No Comments »
